Although the specific regulatory mechanisms remain unclear, this study suggests that LRRC8A contributes to immune evasion and creates a pro-tumor microenvironment, explaining why high LRRC8A expression serves as a negative prognostic indicator for pancreatic cancer patients. Here, LRRC8A is linked to familial pancreatic carcinoma.